European Neuropsychopharmacology
Volume 20, Issue 6 , Pages 405-413 , June 2010

Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system

  • Ying Xu

      Affiliations

    • J. Crayton Pruitt Family Department of Biomedical Engineering and Evelyn F. & William L. Mcknight Brain Institute, University of Florida, Gainesville, FL, 32611, USA
    • ,
  • Zhichao Wang

      Affiliations

    • Department of Neurosurgery, Beijing Haidian Hospital, 29th Zhongguancun Street, Haidian District, Beijing, 100080, PR China
    • ,
  • Wenting You

      Affiliations

    • Institute of Experimental Neurobiology, Wenzhou Medical College, Wenzhou, 325021, PR China
    • ,
  • Xiuhua Zhang

      Affiliations

    • Institute of Experimental Neurobiology, Wenzhou Medical College, Wenzhou, 325021, PR China
    • ,
  • Shan Li

      Affiliations

    • Institute of Experimental Neurobiology, Wenzhou Medical College, Wenzhou, 325021, PR China
    • ,
  • Philip A. Barish

      Affiliations

    • J. Crayton Pruitt Family Department of Biomedical Engineering and Evelyn F. & William L. Mcknight Brain Institute, University of Florida, Gainesville, FL, 32611, USA
    • ,
  • Matthew M. Vernon

      Affiliations

    • J. Crayton Pruitt Family Department of Biomedical Engineering and Evelyn F. & William L. Mcknight Brain Institute, University of Florida, Gainesville, FL, 32611, USA
    • ,
  • Xia Du

      Affiliations

    • Institute of Experimental Neurobiology, Wenzhou Medical College, Wenzhou, 325021, PR China
    • ,
  • Gaowen Li

      Affiliations

    • Institute of Experimental Neurobiology, Wenzhou Medical College, Wenzhou, 325021, PR China
    • ,
  • Jianchun Pan

      Affiliations

    • Institute of Experimental Neurobiology, Wenzhou Medical College, Wenzhou, 325021, PR China
    • Corresponding Author InformationCorresponding authors. Ogle is to be contacted at J. Crayton Pruitt Family Department of Biomedical Engineering and Evelyn F. & William L. Mcknight Brain Institute, Institute on Aging, University of Florida, Gainesville, FL 32611, USA. Tel.: +1 352 273 5877; fax: +1 352 392 9791. Pan, Tel.: +86 577 86689982; fax: +86 577 86689983.
    • ,
  • William O. Ogle

      Affiliations

    • J. Crayton Pruitt Family Department of Biomedical Engineering and Evelyn F. & William L. Mcknight Brain Institute, University of Florida, Gainesville, FL, 32611, USA
    • Corresponding Author InformationCorresponding authors. Ogle is to be contacted at J. Crayton Pruitt Family Department of Biomedical Engineering and Evelyn F. & William L. Mcknight Brain Institute, Institute on Aging, University of Florida, Gainesville, FL 32611, USA. Tel.: +1 352 273 5877; fax: +1 352 392 9791. Pan, Tel.: +86 577 86689982; fax: +86 577 86689983.

Received 24 November 2009 ,Revised 2 February 2010 ,Accepted 26 February 2010.

References 

  1. Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB, Yang K, et al. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci. 2010;101:488–493
  2. Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 2006;7:137–151
  3. Bhutani MK, Bishnoi M, Kulkarni SK. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol. Biochem. Behav. 2009;92:39–43
  4. Blier P, De Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 1994;15:220–226
  5. Bortolato M, Chen K, Shih JC. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv. Drug Deliv. Rev. 2008;60:1527–1533
  6. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 1976;72:248–254
  7. Butterweck V, Bockers T, Korte B, Bittkowski W, Winterhoff H. Long-term effects of St. John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus. Brain Res. 2002;930:21–29
  8. Chen LW, Wang YQ, Wei LC, Shi M, Chan YS. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease. CNS Neurol. Disord. Drug Targets. 2007;6:273–281
  9. Dasgupta B, Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. PNAS. 2007;104:7217–7222
  10. Deniker P. The search for new antidepressants and related drugs. In:  Tipton KF,  Dostert D,  Benedetti MS editor. Monoamine Oxidase and Diseases, Prospects for Therapy with Reversible Inhibitors. New York, NY: Academic Press; 1984;p. 3–8
  11. Dhingra D, Sharma A. Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2006;30:449–454
  12. Dremencov E, Mansari MEI, Blier P. Brain norepinephrine system as a target for antidepressant and mood stabilizing medications. Curr. Drug Targets. 2009;10:1061–1068
  13. Eren I, Naziroglu M, Demirdas A. Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem. Res. 2007;32:1188–1195
  14. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press; 1997;
  15. Guiard BP, Mansari MEI, Blier P. Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors. Curr. Drug Targets. 2009;10:1069–1084
  16. Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M, et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch. Med. Res. 2007;38:247–252
  17. Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology. 2008;201:435–442
  18. Kumar A, Naidu PS, Seghal N, Padi SS. Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology. 2007;79:17–26
  19. Langer SZ. Presynaptic receptors and their role in the regulation of transmitter release. Br. J. Pharmacol. 1977;60:481–497
  20. Mazzio EA, Harris N, Soliman KF. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells. Planta Med. 1998;64(7):603–606
  21. Nitta A, Furukawa Y, Hayashi K, Hiramatsu M, Kameyama T, Nabeshima T. Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain. Neurosci. Lett. 1992;144:152
  22. Pineyro G, Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 1999;51:533–591
  23. Porsolt RD, Pichon MLE, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressant. Arch. Int. Pharmacodyn. Ther. 1977;229:327–336
  24. Porsolt RD, Bertin A, Jalfre M. Behavioural despair in rats and mice: strain differences and the effects of imipramine. Eur. J. Pharmacol. 1978;51:291–294
  25. Puech AJ, Chermat R, Poncelet M, Doare L, Simon P. Antagonism of hypothermia and behavioral response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics. Psychopharmacology. 1981;75:84–91
  26. Ranney A, Petro MS. Resveratrol protects spatial learning in middle-aged C57BL/6 mice from effects of ethanol. Behav. Pharmacol. 2009;20:330–336
  27. Redrobe JP, Bourin M, Colombel MC, Baker GB. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms. J. Psychopharmacol. 1998;12:348–355
  28. Redrobe JP, Dumont Y, Fournier A, Baker GB, Quirion R. Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NYP) in the mouse forced swim test. Peptides. 2005;26:1394–1400
  29. Sale S, Verschoyle RD, Boocock D, Jones DJL, Wilsher N, Ruparelia KC, et al. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3, 4, 5, 4′-tetramethoxystilbene. Br. J. Cancer. 2004;90:736–744
  30. Skaer TL, Sclar DA, Robison LM. Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: an assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent Psychiatry. Clin. Ther. 2009;31:1478–1487
  31. Stahl SM, Felker A. Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants. CNS Spectr. 2008;13:855–870
  32. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 1985;85:367–370
  33. Thachil AF, Mohan R, Bhugra D. The evidence base of complementary and alternative therapies in depression. J. Affect. Disord. 2007;97:23–35
  34. Tredici G, Miloso M, Nicolini G, Galbiati S, Cavaletti G, Bertelli A. Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant?. Drugs Exp. Clin. Res. 1999;25:99–103
  35. Viana A, Rego JCD, Poser GV, Ferraz A, Heckler AR, Costentin J, et al. The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht on forced swimming test results from an inhibition of neuronal monoamine uptake. Neuropharmacology. 2005;49:1042–1052
  36. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, et al. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 2003;72:2219–2233
  37. Wang R, Xu Y, Wu HL, Li YB, Li YH, Guo JB, et al. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur. J. Pharmacol. 2008;578:43–50
  38. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, et al. The effects of curcumin on depressive-like behaviors in mice. Eur. J. Pharmacol. 2005;518:40–46
  39. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, et al. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol. Biochem. Behav. 2005;82:200–206
  40. Xu Y, Ku BS, Lu T, Yao HY, Jiang WG, Ma X, et al. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res. 2006;1122:56–64
  41. Yáñez M, Fraiz N, Cano E, Orallo F. Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem. Biophys. Res. Commun. 2006;344:688–695
  42. Yáñez M, Fraiz N, Cano E, Orallo F. (−)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity. Eur. J. Pharmacol. 2006;542:54–60

PII: S0924-977X(10)00046-5

doi: 10.1016/j.euroneuro.2010.02.013

European Neuropsychopharmacology
Volume 20, Issue 6 , Pages 405-413 , June 2010

Article Tools

* Image Usage & Resolution